Rheumatologic manifestations of cancer

Med Clin North Am. 1986 Mar;70(2):385-417. doi: 10.1016/s0025-7125(16)30960-9.

Abstract

A variety of musculoskeletal syndromes have been described in association with malignancy. The majority of such descriptions have dealt with the connective tissue disorder as a paraneoplastic syndrome, frequently the presenting feature of an otherwise occult malignancy. This may range from the well known syndrome of HOA, heralding lung cancer, to a lesser known association of pyogenic arthritis due to an unusual enteric pathogen, signaling colon cancer. Conversely, the connective tissue disorder may precede the malignancy, and by virtue of its pathophysiology or its therapy, foster the subsequent development of cancer. Awareness of these associations may lead to earlier cancer detection, and hence, potentially more effective therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amyloidosis / etiology
  • Arthritis / etiology
  • Bone Neoplasms / complications
  • Bone Neoplasms / physiopathology
  • Connective Tissue Diseases / complications
  • Dermatomyositis / etiology
  • Gout / etiology
  • Humans
  • Immune Complex Diseases / etiology
  • Immunosuppressive Agents / adverse effects
  • Joint Diseases / classification
  • Joint Diseases / complications
  • Leukemia / complications
  • Lupus Erythematosus, Systemic / etiology
  • Lymphoma / complications
  • Myositis / etiology
  • Neoplasm Metastasis
  • Neoplasms / chemically induced
  • Neoplasms / classification
  • Neoplasms / complications*
  • Neoplasms, Radiation-Induced
  • Osteoarthropathy, Primary Hypertrophic / etiology
  • Reflex Sympathetic Dystrophy / etiology
  • Rheumatic Diseases / drug therapy
  • Rheumatic Diseases / etiology*
  • Rheumatic Diseases / radiotherapy
  • Scleroderma, Systemic / etiology
  • Syndrome
  • Synovial Membrane / physiopathology
  • Vasculitis / etiology

Substances

  • Immunosuppressive Agents